Uniphar (UPR) Share Price, News & Analysis

Company Overview

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers. The Pharma division provides high value services across the lifecycle of a pharmaceutical product; and healthcare professionals with access to medicines it cannot source through traditional channels, as well as operates its on demand and pharma service units. The Supply Chain & Retail division engages in pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons; and operates a network of pharmacies under the Life, Allcare, and Hickey's brands. It also offers pharmacy support, pharmaceutical supply chain, specialist nursing and infusion, medical device distribution, healthcare technology, outsourcing and resourcing, telecommunications support, pharmaceutical advisory, medical affairs, and online pharmacy and product fostering services, as well as specialist provider of pharmaceuticals. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.

Key Stats

• Today's Range: 175 to 179
• 50-Day Range: 169 to 228
• 52-Week Range: 166 to 256
• Volume: 13,672 shs
• Average Volume: 37,093 shs
• Market Capitalization: £488.71 million
• P/E Ratio: 1,278.57
• Dividend Yield: 1.12%
• Price Target: GBX 310
• Consensus Rating: Buy

UPR Stock Analysis - Frequently Asked Questions

How have UPR shares performed this year?

Uniphar's stock was trading at GBX 224 at the beginning of 2024. Since then, UPR stock has decreased by 20.1% and is now trading at GBX 179.
View the best growth stocks for 2024 here.

How do I buy shares of Uniphar?

Shares of UPR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Uniphar own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Uniphar investors own include IXICO (IXI) and ANGLE (AGL).

Company Calendar

• Ex-Dividend for 10/4 Dividend: 9/12/2024
• Dividend Payable: 10/04/2024
• Today: 11/23/2024

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Distribution
• Sub-Industry: N/A
• Current Symbol: LON:UPR
• CUSIP: N/A
• CIK: N/A
• Web: www.uniphar.ie
• Phone: 353 1 428 7777
• Fax: N/A
• Employees: 3,000
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: GBX 310
• High Stock Price Target: GBX 310
• Low Stock Price Target: GBX 310
• Potential Upside/Downside: +73.2%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): GBX 0.14
• Trailing P/E Ratio: 1,278.57
• Forward P/E Ratio: 9.51
• P/E Growth: N/A
• Net Income: £45.17 million
• Net Margins: 1.69%
• Pretax Margin: N/A
• Return on Equity: 13.91%
• Return on Assets: 3.76%

Debt

• Debt-to-Equity Ratio: 119.43
• Current Ratio: 0.90
• Quick Ratio: 0.60

Sales & Book Value

• Annual Sales: £2.68 billion
• Price / Sales: 0.18
• Cash Flow: GBX 17.96 per share
• Price / Cash Flow: 9.97
• Book Value: GBX 128 per share
• Price / Book: 1.40

Miscellaneous

• Outstanding Shares: 273,020,000
• Free Float: N/A
• Market Cap: £488.71 million
• Optionable: Not Optionable
• Beta: 0.75